IPO - Forte Biosciences, Inc.

Form Type: 8-K

Filing Date: 2025-06-25

Corporate Action: Ipo

Type: New

Accession Number: 000119312525147017

Filing Summary: On June 24, 2025, Forte Biosciences, Inc. entered into an Underwriting Agreement with multiple underwriters relating to a public offering of 5,630,450 shares of its common stock at a price of $12.00 per share. Additionally, pre-funded warrants to purchase 619,606 shares at $11.999 each are being offered. The total gross proceeds are expected to be approximately $75 million, with net proceeds estimated at $70 million after expenses. The company will use these funds for operating expenses through 2027. The offering is pending customary closing conditions and is set to close around June 26, 2025. Furthermore, the Underwriting Agreement includes customary representations and warranties, indemnification, and termination provisions.